Literature DB >> 3276316

Molecular basis of the activity of antibiotics of the vancomycin group.

D H Williams1, J P Waltho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3276316     DOI： 10.1016/0006-2952(88)90765-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  Activity of glycopeptides against vancomycin-resistant gram-positive bacteria.

Authors:  T I Nicas; C T Cole; D A Preston; A A Schabel; R Nagarajan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.

Authors:  Deborah L Higgins; Ray Chang; Dmitri V Debabov; Joey Leung; Terry Wu; Kevin M Krause; Erik Sandvik; Jeffrey M Hubbard; Koné Kaniga; Donald E Schmidt; Qiufeng Gao; Robert T Cass; Dane E Karr; Bret M Benton; Patrick P Humphrey
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Different modes of vancomycin and D-alanyl-D-alanine peptidase binding to cell wall peptide and a possible role for the vancomycin resistance protein.

Authors:  J R Knox; R F Pratt
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  Thermodynamic analysis of the interaction of the antibiotic teicoplanin and its aglycone with cell-wall peptides.

Authors:  P Arriaga; J Laynez; M Menendez; J Cañada; F Garcia-Blanco
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

5.  Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.

Authors:  T I Nicas; D L Mullen; J E Flokowitsch; D A Preston; N J Snyder; M J Zweifel; S C Wilkie; M J Rodriguez; R C Thompson; R D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 6.  Natural Products as Platforms To Overcome Antibiotic Resistance.

Authors:  Sean E Rossiter; Madison H Fletcher; William M Wuest
Journal:  Chem Rev       Date:  2017-09-27       Impact factor: 60.622

7.  Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.

Authors:  N E Allen; J N Hobbs; T I Nicas
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

8.  Vancomycin forms ligand-mediated supramolecular complexes.

Authors:  Patrick J Loll; Ariss Derhovanessian; Maxim V Shapovalov; Jeffrey Kaplan; Lin Yang; Paul H Axelsen
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 9.  Glycopeptide antibiotics: from conventional molecules to new derivatives.

Authors:  Françoise Van Bambeke; Yves Van Laethem; Patrice Courvalin; Paul M Tulkens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.